Nunn A, Sinilaite A, Warshawsky B, Salvadori MI, B. Avian influenza and use of the H5N1 vaccine to prevent zoonotic infection in Canada. CMAJ. 2025 Jun 1;197(21):E599-E600
Key points
Outbreaks of avian influenza A(H5N1) clade 2.3.4.4b viruses continue to be widespread among birds and poultry in many parts of the world, with transmission to mammals including humans in some countries and dairy cattle in the United States.
These viruses are considered to have pandemic potential owing to their ability to infect and spread among mammals, their historically high mortality rate in humans, and the general lack of immunity in the human population.
Although the current risk of infection for the public remains low, Health Canada recently authorized an H5N1 influenza vaccine that may benefit certain people with increased risk of exposure to the virus, such as those who work with the virus in laboratory settings or are involved in culling infected poultry, as an added layer of protection in addition to other preventive measures.
Ongoing monitoring of the immune response to H5 influenza vaccines against circulating avian influenza strains will help to inform whether updated vaccines are needed.
Outbreaks of avian influenza A(H5N1) clade 2.3.4.4b viruses continue to be widespread among birds and poultry in many parts of the world, with transmission to mammals including humans in some countries and dairy cattle in the United States.
These viruses are considered to have pandemic potential owing to their ability to infect and spread among mammals, their historically high mortality rate in humans, and the general lack of immunity in the human population.
Although the current risk of infection for the public remains low, Health Canada recently authorized an H5N1 influenza vaccine that may benefit certain people with increased risk of exposure to the virus, such as those who work with the virus in laboratory settings or are involved in culling infected poultry, as an added layer of protection in addition to other preventive measures.
Ongoing monitoring of the immune response to H5 influenza vaccines against circulating avian influenza strains will help to inform whether updated vaccines are needed.
See Also:
Latest articles in those days:
- The evolution and transmission dynamics of H3N2 influenza virus identified in a respiratory disease outbreak in companion dogs in Alabama, USA 6 hours ago
- Structural and functional characterization of hemagglutinin E190D and Q226H minor variants in human H5N1 A/British Columbia/PHL-2032/2024 6 hours ago
- Spatial risk factors associated with outbreaks of highly pathogenic avian influenza in Pennsylvania’s commercial poultry farms 6 hours ago
- [preprint]H9N2 avian influenza virus in Bangladesh: three genetically distinct co-circulating subgroups retain a largely conserved antigenic phenotype 6 hours ago
- [preprint]Endogenous serine proteases in MDCK sublines support trypsin-independent influenza A virus replication 6 hours ago
[Go Top] [Close Window]


